Physician Assistant · Lewes, DE
NPI
1114933793
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
34431 King Street Row
Lewes, DE, 19958
Phone (302) 645-2666
Groups this clinician bills Medicare through
Medicare paid, 2024
$197K
12,475 services
Medicare patients, 2024
900
Average age 76
Drug cost, 2024
$283K
2,309 prescriptions
Company payments, 2025
$314
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christine M Martindale was code J9030 (bcg live intravesical instillation, 1 mg), 6,200 times for 33 patients. In total Christine M Martindale billed 12,475 services in 24 codes, and Medicare paid $197K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 6,200 | 33 | $2.27 | $14K |
| 99213 Office E&M - Established | Office | 913 | 658 | $53.98 | $49K |
| 51798 Ultrasound - Nonspecific | Office | 840 | 618 | $7.76 | $6,522 |
| 82570 Clinical Chemistry | Office | 657 | 466 | $5.06 | $3,327 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 522 | 74 | $140.17 | $73K |
| 81003 Clinical Chemistry | Office | 428 | 311 | $2.19 | $937 |
| 99214 Office E&M - Established | Office | 234 | 217 | $75.14 | $18K |
| 81001 Clinical Chemistry | Office | 225 | 190 | $3.11 | $700 |
| 96402 Chemotherapy Administration | Office | 129 | 75 | $20.93 | $2,700 |
| 51720 Chemotherapy Administration | Office | 124 | 33 | $58.05 | $7,198 |
| 99204 Office E&M - New | Office | 61 | 61 | $80.88 | $4,934 |
| 51702 Other Organ Systems | Office | 60 | 28 | $39.17 | $2,350 |
| 99212 Office E&M - Established | Office | 39 | 30 | $37.93 | $1,479 |
| 99211 Office E&M - Established | Office | 32 | 28 | $14.63 | $468 |
| 99215 Office E&M - Established | Office | 19 | 19 | $103.97 | $1,975 |
By year: 2022 $193K for 14,685 services; 2023 $238K for 20,628 services; 2024 $197K for 12,475 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82570 Clinical Chemistry | 657 | 466 | $5.06 | $3,327 |
| 81003 Clinical Chemistry | 428 | 311 | $2.19 | $937 |
| 81001 Clinical Chemistry | 225 | 190 | $3.11 | $700 |
Medicare prescription drug claims, 2024
In 2024, the drug Christine M Martindale prescribed most often to Medicare patients was Tamsulosin Hcl, with 593 prescriptions and refills. In total Christine M Martindale wrote 2,309 Medicare prescriptions that cost $283K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 593 | 1,693 | 196 | $12K |
| Solifenacin Succinate Generic | 380 | 811 | 135 | $14K |
| Finasteride Generic | 322 | 964 | 105 | $5,735 |
| Myrbetriq Mirabegron | 152 | 346 | 61 | $152K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 101 | 101 | 81 | $359 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 99 | 269 | 42 | $2,882 |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 88 | 206 | 28 | $14K |
| Cephalexin Generic | 81 | 173 | 50 | $954 |
| Ciprofloxacin Hcl Generic | 65 | 65 | 54 | $496 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 63 | 63 | 51 | $1,065 |
| Estradiol Generic | 56 | 151 | 38 | $3,957 |
| Gemtesa Vibegron | 55 | 138 | 22 | $63K |
| Silodosin Generic | 40 | 102 | 19 | $3,939 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 27 | 81 | Under 11 | $578 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 21 | 45 | Under 11 | $1,324 |
Brand drugs: - claims; generic drugs: 2,076 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christine M Martindale $314 ($314 in general payments such as food, travel and fees) from 10 companies. The largest payer was Sumitomo Pharma America, Inc. with $53.59.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 2 | $53.59 |
| Abbvie Inc. ABBV | 2 | $45.37 |
| Boston Scientific Corporation BSX | 1 | $43.14 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $31 |
| Urogen Pharma, Inc. URGN | 1 | $25.86 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $25.12 |
| 180 Medical, Inc. | 1 | $23.71 |
| Tolmar, Inc. | 1 | $23.47 |
| Ferring Pharmaceuticals Inc. | 1 | $23.18 |
| Calyxo, Inc. | 1 | $19.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.